West Pharmaceutical Services Inc (WST)
Debt-to-capital ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 2,682,300 | 2,881,000 | 2,684,900 | 2,335,400 | 1,854,500 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $2,682,300K)
= 0.00
The debt-to-capital ratio of West Pharmaceutical Services Inc has remained stable at 0.00 from December 31, 2020, to December 31, 2024. A debt-to-capital ratio of 0.00 indicates that the company has not utilized any debt in its capital structure during this period. This suggests a conservative financial approach with minimal reliance on debt financing and a strong capital position. It signifies that the company's operations are primarily funded by equity, which can indicate financial stability and lower financial risk. Investors and stakeholders may view this as a positive sign of financial health and prudent risk management by West Pharmaceutical Services Inc.
Peer comparison
Dec 31, 2024